Mantegazza R, Wolfe GI, Muppidi S, Wiendl H, et al. Post-intervention status in patients with refractory myasthenia gravis treated with eculizumab during REGAIN and its open-label extension. Neurology 2020 Nov 23. pii: WNL.0000000000011207.
PMID: 33229455